The authors showed that post oncolytic HSV (oHSV) virotherapy activated AKT signaling results in an enrichment of glioblastoma stem-like cells signatures in glioma.
[Molecular Therapy Oncolytics]
oHSV-P10 Reduces Glioma Stem Cell Enrichment after Oncolytic HSV Therapy.
